458 related articles for article (PubMed ID: 9695744)
21. Effect of galardin on collagen degradation by Pseudomonas aeruginosa.
Hao JL; Nagano T; Nakamura M; Kumagai N; Mishima H; Nishida T
Exp Eye Res; 1999 Dec; 69(6):595-601. PubMed ID: 10620388
[TBL] [Abstract][Full Text] [Related]
22. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
[TBL] [Abstract][Full Text] [Related]
23. Membrane independent activation of fibroblast proMMP-2 by snake venom: novel roles for venom proteinases.
Saravia-Otten P; Frisan T; Thelestam M; Gutiérrez JM
Toxicon; 2004 Dec; 44(7):749-64. PubMed ID: 15500851
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
Zervos EE; Shafii AE; Rosemurgy AS
J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060
[TBL] [Abstract][Full Text] [Related]
25. [Effects of interaction between vascular endothelial cells and monocytes on expression of matrix metalloproteinase-2 and of tissue inhibitor of metalloproteinases 2 and regulation of pravastatin].
Zheng W; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):105-8. PubMed ID: 15842807
[TBL] [Abstract][Full Text] [Related]
26. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.
Imai K; Yokohama Y; Nakanishi I; Ohuchi E; Fujii Y; Nakai N; Okada Y
J Biol Chem; 1995 Mar; 270(12):6691-7. PubMed ID: 7896811
[TBL] [Abstract][Full Text] [Related]
28. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
Lafleur MA; Forsyth PA; Atkinson SJ; Murphy G; Edwards DR
Biochem Biophys Res Commun; 2001 Mar; 282(2):463-73. PubMed ID: 11401482
[TBL] [Abstract][Full Text] [Related]
29. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis.
Pollitt CC; Pass MA; Pollitt S
Equine Vet J Suppl; 1998 Sep; (26):119-24. PubMed ID: 9932102
[TBL] [Abstract][Full Text] [Related]
30. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
31. In vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivo.
Rigot V; Marbaix E; Lemoine P; Courtoy PJ; Eeckhout Y
Biochem J; 2001 Aug; 358(Pt 1):275-80. PubMed ID: 11485578
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
[TBL] [Abstract][Full Text] [Related]
33. Temporal relationship between MMP production and angiogenic process in HUVECs.
Kiran MS; Sameer Kumar VB; Viji RI; Sudhakaran PR
Cell Biol Int; 2006 Sep; 30(9):704-13. PubMed ID: 16829143
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.
Grenier D; Plamondon P; Sorsa T; Lee HM; McNamara T; Ramamurthy NS; Golub LM; Teronen O; Mayrand D
J Periodontol; 2002 Jan; 73(1):79-85. PubMed ID: 11846203
[TBL] [Abstract][Full Text] [Related]
35. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
Stack MS; Itoh Y; Young TN; Nagase H
Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
[TBL] [Abstract][Full Text] [Related]
37. Ulex europaeus I lectin induces activation of matrix-metalloproteinase-2 in endothelial cells.
Gomez DE; Yoshiji H; Kim JC; Thorgeirsson UP
Biochem Biophys Res Commun; 1995 Nov; 216(1):177-82. PubMed ID: 7488085
[TBL] [Abstract][Full Text] [Related]
38. Temporal expression and activation of matrix metalloproteinases-2, -9, and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia.
Muhs BE; Plitas G; Delgado Y; Ianus I; Shaw JP; Adelman MA; Lamparello P; Shamamian P; Gagne P
J Surg Res; 2003 May; 111(1):8-15. PubMed ID: 12842442
[TBL] [Abstract][Full Text] [Related]
39. Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts.
Partridge CA; Phillips PG; Niedbala MJ; Jeffrey JJ
Am J Physiol; 1997 May; 272(5 Pt 1):L813-22. PubMed ID: 9176243
[TBL] [Abstract][Full Text] [Related]
40. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase.
Foda HD; George S; Conner C; Drews M; Tompkins DC; Zucker S
Lab Invest; 1996 Feb; 74(2):538-45. PubMed ID: 8780171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
